Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 323 results found. Search for [ oxford vaccine ]

Results 1 to 21 of 323
Reuters
September 18, 2020
The decision by one of the U.N. agency's biggest supporters is a big blow to its strategy aimed at uniting governments around the world to fight the coronavirus pandemic together


BusinessToday.In
September 17, 2020
Addressing the Rajya Sabha over the coronavirus situation in the country, Dr. Harsh Vardhan said that India is also making efforts like other nations, adding that \"three vaccine candidates are in different phases\" of clinical trials


Rajeev Dubey, Dipak Mondal and Joe C Mathew
New Delhi, September 17, 2020
With GDP contracting 24 per cent in first quarter, economic recovery will be a long and painful process. Business Today's Rajeev Dubey, Dipak Mondal and Joe C. Mathew caught up with Chief Economic Advisor Krishnamurthy Subramanian on the state of the economy and plans to put it back on track. Edited excerpts:


BusinessToday.In
September 17, 2020
Adar Poonawalla-helmed Serum Institute had partnered with Novavax in August for the production of its coronavirus vaccine. The US drug developer plans to manufacture 2 billion doses annually


BusinessToday.In
September 16, 2020
Coronavirus vaccine trials: While China has four vaccine candidates in third or final stages of clinical trials, there are at least two companies from the United States and one from UK and Germany, which are planning to rollout vaccine before December, if everything goes as per the plan


BusinessToday.In
September 16, 2020
Former Wipro CEO and Managing Director Abidali Neemuchwala has joined Dallas Venture Partners (DVP) as a venture partner


Reuters
September 16, 2020
China launched a vaccine emergency use programme in July, offering three experimental shots developed by a unit of state pharmaceutical giant China National Pharmaceutical Group (Sinopharm) and U.S.-listed Sinovac Biotech


PTI
September 16, 2020
Rajesh Khullar has held several positions at the Centre including as Joint Secretary in the Department of Economic Affairs in the Ministry of Finance


BusinessToday.In
September 16, 2020
Besides, the drug regulating body of the country has told the Serum Institute to take extra care during screening, provide additional information in informed consent, and closely monitor participants for any adverse events during follow-up of the study


BusinessToday.In
September 15, 2020
COVID-19 vaccine candidates being developed by Cadila Healthcare and Bharat Biotech have completed the phase one of the study while Pune-based Serum Institute of India (SII) will begin with Phase 3 clinical trial after getting regulatory nod, says ICMR chief


BusinessToday.In
September 15, 2020
Where the UK has resumed the clinical tests of AstraZeneca's COVID-19 vaccine candidate following a review by the country's drug regulator and an independent safety review committee, trials paused in India, US, and South Africa are yet to resume


BusinessToday.In
September 15, 2020
India Stock Market Highlights Today: Titan, followed by Sun Pharma, HDFC, ICICI Bank, Bajaj Finance, NTPC, HDFC Bank and M&M were among the major gainers on Sensex pack today. On the other hand, Tech Mahindra, HCL Tech, Kotak Bank, ITC and Bharti Airtel were among the laggards


Reuters
September 15, 2020
Enrollment in AstraZeneca's global trials of the vaccine, which it is developing with researchers at Oxford University, was put on pause on September 6


BusinessToday.In
September 14, 2020
The DCGI had issued a show-cause notice to Serum Institute of India on September 9 for not informing it about AstraZeneca pausing clinical trials of the vaccine candidate in other countries


BusinessToday.In
September 13, 2020
Union Health Minister Harsh Vardhan on Sunday said that he will be the first person to take COVID-19 vaccine so as to dispel the \"trust deficit\" around the same


BusinessToday.In
September 13, 2020
Pfizer says trial is event-based and there are many variables that will ultimately impact read-out timing; adds if trials are successful, these companies would submit vaccines for approval as early as October


BusinessToday.In
September 12, 2020
\"Once DCGI (Drugs Controller General of India) gives us permission to restart the trials in India, we will resume the trials,\" SII CEO Adar Poonawalla said on Saturday


BusinessToday.In
September 12, 2020
The committee \"has concluded its investigations and recommended to the MHRA that trials in the UK are safe to resume\", AstraZeneca' said


BusinessToday.In
September 12, 2020
Bharat Biotech says its vaccine candidate was found to generate \"robust immune responses\", thus preventing infection and disease in primates upon high amounts of exposure to live SARS-CoV-2 virus


BusinessToday.In
New Delhi, September 12, 2020
Delhi Metro resumed its full services on Saturday with the Airport Express Line reopening after a hiatus of over 170 days due to the COVID-19 pandemic; Drug Controller General of India (DCGI) Dr VG Somani has ordered Serum Institute of India (SII) to suspend any new recruitment in Phase 2 and 3 clinical trials for the Oxford-AstraZeneca coronavirus vaccine candidate till further notice; Millions of coronavirus cases may have gone undetected in India earlier this year, a research paper estimates. Watch this and more on News Blast.Also Read: RBI continues to remain net buyer of US dollar in July, purchases $15.973 billion


PAGES 1 OF 17  12345